SCHEMBL7400896

SCHEMBL7400896

[CH](CN1CCNCC1)c1ccccn1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLD1 Q13393 1/20 0.47
ALDH1A1 P00352 3/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
TSHR P16473 2/20 0.47
ALOX15 P16050 1/20 0.47
KDM4E B2RXH2 2/20 0.43
HSD17B10 Q99714 2/20 0.43
GAA P10253 1/20 0.43
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
ATM Q13315 1/20 0.42
SIGMAR1 Q99720 2/20 0.42
HTR7 P34969 2/20 0.41
MAPK1 P28482 2/20 0.41
IKBKB O14920 1/20 0.41
RAF1 P04049 1/20 0.41
RPS6KB1 P23443 1/20 0.41
AKT1 P31749 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3939449 0.83 RAB9A (0.45) ALDH1A1TSHRKDM4EGAAMEN1
SCHEMBL7742156 0.80 ALDH1A1 (0.44) PLD1ALDH1A1L3MBTL1TSHRALOX15
SCHEMBL3593807 0.76 PLD1 (0.53) PLD1ALDH1A1L3MBTL1TSHRALOX15
SCHEMBL2430208 0.74 SIGMAR1 (0.53) ALDH1A1GAAMEN1KMT2ASIGMAR1
SCHEMBL8168671 0.74 KDM4E (0.51) ALDH1A1KDM4EHSD17B10MEN1KMT2A
SCHEMBL209471 0.71 ALDH1A1 (0.61) PLD1ALDH1A1L3MBTL1TSHRALOX15
SCHEMBL4903097 0.71 ALDH1A1 (0.61) PLD1ALDH1A1L3MBTL1TSHRALOX15
SCHEMBL17485679 0.71 ALDH1A1 (0.61) PLD1ALDH1A1L3MBTL1TSHRALOX15
SCHEMBL3387061 0.70 ALDH1A1 (0.60) PLD1ALDH1A1L3MBTL1TSHRALOX15
SCHEMBL3432550 0.70 ALDH1A1 (0.60) ALDH1A1L3MBTL1TSHRALOX15KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6133446-A Heterocyclic compounds for the treatment of CNS and cardiovascular disorders PHARMACIA & UPJOHN COMPANY (US) 2000-10-17 US disclosed
EP-0737189-B1 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS UPJOHN CO (US) 1999-07-28 EP disclosed
US-5877317-A Heterocyclic compounds for the treatment of CNS and cardiovascular disorders PHARMACIA & UPJOHN COMPANY (US) 1999-03-02 US disclosed
EP-0836599-A1 1,6-DISUBSTITUTED ISOCHROMANS FOR TREATMENT OF MIGRAINE HEADACHES PHARMACIA & UPJOHN COMPANY (US) 1998-04-22 EP disclosed
WO-1997002259-A1 1,6-DISUBSTITUTED ISOCHROMANS FOR TREATMENT OF MIGRAINE HEADACHES PHARMACIA & UPJOHN COMPANY (US) 1997-01-23 WO disclosed
EP-0737189-A1 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS PHARMACIA & UPJOHN COMPANY (US) 1996-10-16 EP disclosed
WO-1995018118-A1 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS THE UPJOHN COMPANY (US) 1995-07-06 WO disclosed